Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-139.18%
operating margin TTM
-17.42%
revenue TTM
243.25 Million
revenue per share TTM
3.99$
valuation ratios | |
|---|---|
| pe ratio | -6.81 |
| peg ratio | 0.00 |
| price to book ratio | -603.16 |
| price to sales ratio | 9.79 |
| enterprise value multiple | -7.23 |
| price fair value | -603.16 |
profitability ratios | |
|---|---|
| gross profit margin | 81.7% |
| operating profit margin | -17.42% |
| pretax profit margin | -138.75% |
| net profit margin | -139.18% |
| return on assets | -82.32% |
| return on equity | -410.2% |
| return on capital employed | -13.09% |
liquidity ratios | |
|---|---|
| current ratio | 2.86 |
| quick ratio | 2.74 |
| cash ratio | 1.48 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 83.16 |
| operating cycle | 169.00 |
| days of payables outstanding | 75.60 |
| cash conversion cycle | 93.40 |
| receivables turnover | 4.25 |
| payables turnover | 4.83 |
| inventory turnover | 4.39 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.73 |
| debt equity ratio | -72.97 |
| long term debt to capitalization | 1.01 |
| total debt to capitalization | 1.01 |
| interest coverage | -8.01 |
| cash flow to debt ratio | -0.60 |
cash flow ratios | |
|---|---|
| free cash flow per share | -7.23 |
| cash per share | 6.92 |
| operating cash flow per share | -7.20 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -0.60 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -213.30 |
Frequently Asked Questions
When was the last time Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) reported earnings?
Mirum Pharmaceuticals, Inc. (MIRM) published its most recent earnings results on 05-08-2026.
What is Mirum Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)'s trailing twelve months ROE is -410.2%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Mirum Pharmaceuticals, Inc. (MIRM) currently has a ROA of -82.32%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did MIRM's net profit margin stand at?
MIRM reported a profit margin of -139.18% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is MIRM's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.86 in the most recent quarter. The quick ratio stood at 2.74, with a Debt/Eq ratio of -72.97.